KORU Medical Systems annual ebitda
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
KORU Medical Systems EBITDA Growth & History (KRMD)
KORU Medical Systems's calculated EBITDA was −$2.2M for fiscal 2025.
View full KORU Medical Systems company overviewKORU Medical Systems annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.2M | $3.4M | — |
| 2024 | 2024-12-31 | −$5.6M | $3.8M | — |
| 2023 | 2023-12-31 | −$9.4M | $794,147 | — |
| 2022 | 2022-12-31 | −$10.2M | −$3.6M | — |
| 2021 | 2021-12-31 | −$6.6M | −$5.7M | — |
| 2020 | 2020-12-31 | −$836,190 | −$1.8M | — |
| 2019 | 2019-12-31 | $925,908 | −$547,891 | −37.18% |
| 2018 | 2018-12-31 | $1.5M | −$19,992 | −1.34% |
| 2017 | 2017-12-31 | $1.5M | $1.9M | — |
| 2016 | 2017-02-28 | −$435,640 | −$1.9M | — |
| 2015 | 2016-02-29 | $1.5M | $21,684 | +1.52% |
| 2014 | 2015-02-28 | $1.4M | $190,636 | +15.37% |
| 2013 | 2014-02-28 | $1.2M | −$12,745 | −1.02% |
| 2012 | 2013-02-28 | $1.3M | −$139,764 | −10.03% |
| 2011 | 2012-02-29 | $1.4M | $132,536 | +10.51% |
| 2010 | 2011-02-28 | $1.3M | — | — |
KORU Medical Systems quarterly ebitda
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q1.16
Q2.16
Q2.16
Q3.16
Q1.17
Q1.17
Q2.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $837,022 | $940,190 | — |
| Q1 2026 | 2026-03-31 | −$667,392 | $360,256 | — |
| Q4 2025 | 2025-12-31 | −$367,929 | $1.0M | — |
| Q3 2025 | 2025-09-30 | −$663,197 | $812,315 | — |
| Q2 2025 | 2025-06-30 | −$103,168 | $871,002 | — |
| Q1 2025 | 2025-03-31 | −$1.0M | $702,348 | — |
| Q4 2024 | 2024-12-31 | −$1.4M | $591,134 | — |
| Q3 2024 | 2024-09-30 | −$1.5M | $99,495 | — |
| Q2 2024 | 2024-06-30 | −$974,170 | $2.0M | — |
| Q1 2024 | 2024-03-31 | −$1.7M | $1.1M | — |
| Q4 2023 | 2023-12-31 | −$2.0M | $354,544 | — |
| Q3 2023 | 2023-09-30 | −$1.6M | −$209,872 | — |
| Q2 2023 | 2023-06-30 | −$3.0M | $475,923 | — |
| Q1 2023 | 2023-03-31 | −$2.8M | $173,552 | — |
| Q4 2022 | 2022-12-31 | −$2.3M | −$323,908 | — |
| Q3 2022 | 2022-09-30 | −$1.4M | −$159,035 | — |
| Q2 2022 | 2022-06-30 | −$3.5M | −$2.2M | — |
| Q1 2022 | 2022-03-31 | −$3.0M | −$919,447 | — |
| Q4 2021 | 2021-12-31 | −$2.0M | −$956,211 | — |
| Q3 2021 | 2021-09-30 | −$1.2M | −$1.7M | — |
| Q2 2021 | 2021-06-30 | −$1.3M | −$325,578 | — |
| Q1 2021 | 2021-03-31 | −$2.1M | −$2.8M | — |
| Q4 2020 | 2020-12-31 | −$1.0M | −$971,630 | — |
| Q3 2020 | 2020-09-30 | $474,463 | −$432,795 | −47.70% |
| Q2 2020 | 2020-06-30 | −$937,061 | −$1.1M | — |
| Q1 2020 | 2020-03-31 | $670,047 | $701,435 | — |
| Q4 2019 | 2019-12-31 | −$72,009 | $283,920 | — |
| Q3 2019 | 2019-09-30 | $907,258 | $346,227 | +61.71% |
| Q2 2019 | 2019-06-30 | $122,047 | −$570,943 | −82.39% |
| Q1 2019 | 2019-03-31 | −$31,388 | −$607,095 | — |
| Q4 2018 | 2018-12-31 | −$355,929 | −$831,763 | — |
| Q3 2018 | 2018-09-30 | $561,031 | $91,136 | +19.39% |
| Q2 2018 | 2018-06-30 | $692,990 | $425,867 | +159.43% |
| Q1 2018 | 2018-03-31 | $575,707 | $294,768 | +104.92% |
| Q4 2017 | 2017-12-31 | $475,834 | $505,049 | — |
| Q2 2017 | 2017-09-30 | $469,895 | $626,556 | — |
| Q1 2017 · Jun 30 | 2017-06-30 | $267,123 | $312,381 | — |
| Q1 2017 · Mar 31 | 2017-03-31 | $280,939 | $669,356 | — |
| Q3 2016 | 2016-11-30 | −$29,215 | $270,231 | — |
| Q2 2016 · Sep 30 | 2016-09-30 | −$156,661 | −$687,392 | — |
| Q2 2016 · Aug 31 | 2016-08-31 | −$45,258 | −$404,747 | — |
| Q1 2016 · Jun 30 | 2016-06-30 | −$388,417 | −$965,292 | — |
| Q1 2016 · May 31 | 2016-05-31 | −$299,446 | −$285,301 | — |
| Q4 2015 | 2016-02-29 | $530,731 | −$3,714 | −0.69% |
| Q3 2015 | 2015-11-30 | $359,489 | $153,511 | +74.53% |
| Q2 2015 | 2015-08-31 | $576,875 | $186,821 | +47.90% |
| Q1 2015 | 2015-05-31 | −$14,145 | −$314,934 | — |
| Q4 2014 | 2015-02-28 | $534,445 | −$34,395 | −6.05% |
| Q3 2014 | 2014-11-30 | $205,978 | −$92,614 | −31.02% |
| Q2 2014 | 2014-08-31 | $390,054 | $196,892 | +101.93% |
| Q1 2014 | 2014-05-31 | $300,789 | $120,753 | +67.07% |
| Q4 2013 | 2014-02-28 | $568,840 | $225,769 | +65.81% |
| Q3 2013 | 2013-11-30 | $298,592 | $159,872 | +115.25% |
| Q2 2013 | 2013-08-31 | $193,162 | −$391,764 | −66.98% |
| Q1 2013 | 2013-05-31 | $180,036 | −$6,622 | −3.55% |
| Q4 2012 | 2013-02-28 | $343,071 | −$239,632 | −41.12% |
| Q3 2012 | 2012-11-30 | $138,720 | −$114,590 | −45.24% |
| Q2 2012 | 2012-08-31 | $584,926 | $382,080 | +188.36% |
| Q1 2012 | 2012-05-31 | $186,658 | −$167,622 | −47.31% |
| Q4 2011 | 2012-02-29 | $582,703 | $276,205 | +90.12% |
| Q3 2011 | 2011-11-30 | $253,310 | $58,592 | +30.09% |
| Q2 2011 | 2011-08-31 | $202,846 | — | — |
| Q1 2011 | 2011-05-31 | $354,280 | — | — |
| Q3 2010 | 2010-11-30 | $306,498 | — | — |
| Q2 2010 | 2010-08-31 | $194,718 | — | — |
KORU Medical Systems ebitda trends
Over the last five reported fiscal years, KORU Medical Systems's ebitda decreased from −$836,190 to −$2.2M, a change of −$1.3M. The latest reported quarter, Q2 2026, shows $837,022.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review KORU Medical Systems filings at SEC.gov ↗